101 related articles for article (PubMed ID: 18058472)
21. Double germline mutations in the RET Proto-oncogene in MEN 2A and MEN 2B kindreds.
Dvorakova S; Vaclavikova E; Ryska A; Cap J; Vlcek P; Duskova J; Kodetova D; Holub V; Novak Z; Bendlova B
Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):192-6. PubMed ID: 16705552
[TBL] [Abstract][Full Text] [Related]
22. [Hereditary medullary thyroid carcinoma--genotype-phenotype characterization].
Frank-Raue K; Heimbach C; Rondot S; Usadel KH; Meng W; Varma C; Fuchs-Hammoser R; Höppner W; Schulze E; Raue F
Dtsch Med Wochenschr; 2003 Sep; 128(39):1998-2002. PubMed ID: 14508694
[TBL] [Abstract][Full Text] [Related]
23. Familial prevalence and age of RET germline mutations: implications for screening.
Machens A; Dralle H
Clin Endocrinol (Oxf); 2008 Jul; 69(1):81-7. PubMed ID: 18062802
[TBL] [Abstract][Full Text] [Related]
24. RET polymorphisms in codons 769 and 836 are not associated with predisposition to medullary thyroid carcinoma.
Wiench M; Włoch J; Wygoda Z; Gubała E; Oczko M; Pawlaczek A; Kula D; Lange D; Jarzab B
Cancer Detect Prev; 2004; 28(4):231-6. PubMed ID: 15350625
[TBL] [Abstract][Full Text] [Related]
25. Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland.
Ciampi R; Romei C; Pieruzzi L; Tacito A; Molinaro E; Agate L; Bottici V; Casella F; Ugolini C; Materazzi G; Basolo F; Elisei R
J Endocrinol Invest; 2017 Jan; 40(1):55-62. PubMed ID: 27535135
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.
Elisei R; Cosci B; Romei C; Bottici V; Renzini G; Molinaro E; Agate L; Vivaldi A; Faviana P; Basolo F; Miccoli P; Berti P; Pacini F; Pinchera A
J Clin Endocrinol Metab; 2008 Mar; 93(3):682-7. PubMed ID: 18073307
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive analysis of RET gene should be performed in patients with multiple endocrine neoplasia type 2 (MEN 2) syndrome and no apparent genotype-phenotype correlation: an appraisal of p.Y791F and p.C634Y RET mutations in five unrelated Brazilian families.
Valente FO; Dias da Silva MR; Camacho CP; Kunii IS; Bastos AU; da Fonseca CC; Simião HP; Tamanaha R; Maciel RM; Cerutti JM
J Endocrinol Invest; 2013 Dec; 36(11):975-81. PubMed ID: 23723040
[TBL] [Abstract][Full Text] [Related]
28. Y791F RET mutation and early onset of medullary thyroid carcinoma in a Brazilian kindred: evaluation of phenotype-modifying effect of germline variants.
Tamanaha R; Camacho CP; Ikejiri ES; Maciel RM; Cerutti JM
Clin Endocrinol (Oxf); 2007 Nov; 67(5):806-8. PubMed ID: 17610518
[No Abstract] [Full Text] [Related]
29. Germline RET sequence variation I852M and occult medullary thyroid cancer: harmless polymorphism or causative mutation?
Machens A; Spitschak A; Lorenz K; Pützer BM; Dralle H
Clin Endocrinol (Oxf); 2011 Dec; 75(6):801-5. PubMed ID: 21711375
[TBL] [Abstract][Full Text] [Related]
30. The risk of medullary thyroid carcinoma in patients with Hirschsprung's disease.
Skába R; Dvoráková S; Václavíková E; Vlcek P; Frantlová M; Bendlová B
Pediatr Surg Int; 2006 Dec; 22(12):991-5. PubMed ID: 17021738
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility.
Toledo RA; Hatakana R; Lourenço DM; Lindsey SC; Camacho CP; Almeida M; Lima JV; Sekiya T; Garralda E; Naslavsky MS; Yamamoto GL; Lazar M; Meirelles O; Sobreira TJ; Lebrao ML; Duarte YA; Blangero J; Zatz M; Cerutti JM; Maciel RM; Toledo SP
Endocr Relat Cancer; 2015 Feb; 22(1):65-76. PubMed ID: 25425582
[TBL] [Abstract][Full Text] [Related]
32. Ret proto-oncogene mutations in apparently sporadic Turkish medullary thyroid carcinoma patients: Turkmen study.
Erdogan MF; Gürsoy A; Ozgen G; Cakir M; Bayram F; Ersoy R; Algün E; Cetinarslan B; Cömlekçi A; Kadioglu P; Balci MK; Yetkin I; Kabalak T; Erdogan G
J Endocrinol Invest; 2005 Oct; 28(9):806-9. PubMed ID: 16370559
[TBL] [Abstract][Full Text] [Related]
33. A novel 9-base pair duplication in RET exon 8 in familial medullary thyroid carcinoma.
Pigny P; Bauters C; Wemeau JL; Houcke ML; Crepin M; Caron P; Giraud S; Calender A; Buisine MP; Kerckaert JP; Porchet N
J Clin Endocrinol Metab; 1999 May; 84(5):1700-4. PubMed ID: 10323403
[TBL] [Abstract][Full Text] [Related]
34. Medullary thyroid carcinoma: pitfalls in diagnosis by fine needle aspiration cytology and relationship of cytomorphology to RET proto-oncogene mutations.
Chang TC; Wu SL; Hsiao YL
Acta Cytol; 2005; 49(5):477-82. PubMed ID: 16334022
[TBL] [Abstract][Full Text] [Related]
35. A new germline point mutation in Ret exon 8 (cys515ser) in a family with medullary thyroid carcinoma.
Fazioli F; Piccinini G; Appolloni G; Bacchiocchi R; Palmonella G; Recchioni R; Pierpaoli E; Silvetti F; Scarpelli M; Bruglia M; Melillo RM; Santoro M; Boscaro M; Taccaliti A
Thyroid; 2008 Jul; 18(7):775-82. PubMed ID: 18631007
[TBL] [Abstract][Full Text] [Related]
36. [Tumor dormancy of hereditary medullary thyroid carcinoma and RET gene mutations].
Yü Y; Gao M; Zhang F
Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):532-3. PubMed ID: 19062722
[No Abstract] [Full Text] [Related]
37. Synchronous metastatic medullary and papillary thyroid carcinomas in a patient with germline RET mutation: case report, molecular analysis, and implications for pathogenesis.
Griffith C; Zhang S; Mukhopadhyay S
Endocr Pathol; 2010 Jun; 21(2):115-9. PubMed ID: 20369307
[TBL] [Abstract][Full Text] [Related]
38. Four novel RET germline variants in exons 8 and 11 display an oncogenic potential in vitro.
Muzza M; Cordella D; Bombled J; Bressac-de Paillerets B; Guizzardi F; Francis Z; Beck-Peccoz P; Schlumberger M; Persani L; Fugazzola L
Eur J Endocrinol; 2010 Apr; 162(4):771-7. PubMed ID: 20103606
[TBL] [Abstract][Full Text] [Related]
39. Occurrence of medullary thyroid carcinoma, bronchial carcinoid tumor, and papillary thyroid carcinoma in a family bearing the RET G691S polymorphism.
Rotondi M; Ercolino T; Fonte R; Lagonigro MS; Leporati P; Villani L; La Manna L; Mannelli M; Chiovato L
J Endocrinol Invest; 2009 Feb; 32(2):115-8. PubMed ID: 19411807
[TBL] [Abstract][Full Text] [Related]
40. Patient affected by neurofibromatosis type 1 and thyroid C-cell hyperplasia harboring pathogenic germ-line mutations in both NF1 and RET genes.
Ercolino T; Lai R; Giachè V; Melchionda S; Carella M; Delitala A; Mannelli M; Fanciulli G
Gene; 2014 Feb; 536(2):332-5. PubMed ID: 24361808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
